Morphoproteomics of VEGF pathway mediators as evidence of reversible resistance to VEGF-TKIs demonstrated by expression of activated ERK and STAT3 in metastatic renal cell carcinoma (mRCC).
Shan Guo
No relevant relationships to disclose
Swetha Siddappa Yadav
No relevant relationships to disclose
Jamie Buryanek
No relevant relationships to disclose
Robert E Brown
No relevant relationships to disclose
Fangqian Ouyang
No relevant relationships to disclose
Robert J. Amato
No relevant relationships to disclose